William L Macias

Drotrecogin alfa (activated) in adults with septic shock.

Andrew Rhodes, Didier Payen, Jyrki Tenhunen, 2012, The New England journal of medicine.

Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes

Jessica L Mega, E. Antman, J. Mega, 2009, Circulation.

Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated).

Massimo Antonelli, I. Douglas, M. Levy, 2007, American journal of respiratory and critical care medicine.

Early changes in organ function predict eventual survival in severe sepsis*

James A Russell, M. Levy, J. Vincent, 2005, Critical care medicine.

Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure*

K. Reinhart, J. Dhainaut, A. Shorr, 2005, Critical care medicine.